214 related articles for article (PubMed ID: 34834284)
1. Formulation and Development of Oral Fast-Dissolving Films Loaded with Nanosuspension to Augment Paroxetine Bioavailability: In Vitro Characterization, Ex Vivo Permeation, and Pharmacokinetic Evaluation in Healthy Human Volunteers.
Elshafeey AH; El-Dahmy RM
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834284
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers.
Alsofany JM; Hamza MY; Abdelbary AA
AAPS PharmSciTech; 2018 Jul; 19(5):2118-2132. PubMed ID: 29700766
[TBL] [Abstract][Full Text] [Related]
3. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation.
Liu C; Chang D; Zhang X; Sui H; Kong Y; Zhu R; Wang W
AAPS PharmSciTech; 2017 Nov; 18(8):2957-2964. PubMed ID: 28462465
[TBL] [Abstract][Full Text] [Related]
4. Development and Characterizations of Pullulan and Maltodextrin-Based Oral Fast-Dissolving Films Employing a Box-Behnken Experimental Design.
Shah KA; Gao B; Kamal R; Razzaq A; Qi S; Zhu QN; Lina S; Huang L; Cremin G; Iqbal H; Menaa F; Cui JH
Materials (Basel); 2022 May; 15(10):. PubMed ID: 35629620
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.
Londhe V; Shirsat R
AAPS PharmSciTech; 2018 Apr; 19(3):1392-1400. PubMed ID: 29396734
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
Rana P; Murthy RS
Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers.
Ahmed TA; Bawazir AO; Alharbi WS; Safo MK
Int J Nanomedicine; 2020; 15():4001-4020. PubMed ID: 32606661
[TBL] [Abstract][Full Text] [Related]
8. A novel oral medicated jelly for enhancement of etilefrine hydrochloride bioavailability:
Hassen Elshafeey A; Moataz El-Dahmy R
Saudi Pharm J; 2022 Oct; 30(10):1435-1447. PubMed ID: 36387345
[TBL] [Abstract][Full Text] [Related]
9. Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation.
Chonkar AD; Rao JV; Managuli RS; Mutalik S; Dengale S; Jain P; Udupa N
Eur J Pharm Biopharm; 2016 Jun; 103():179-191. PubMed ID: 27063592
[TBL] [Abstract][Full Text] [Related]
10. Formulation and optimization of a novel oral fast dissolving film containing drug nanoparticles by Box-Behnken design-response surface methodology.
Shen C; Shen B; Xu H; Bai J; Dai L; Lv Q; Han J; Yuan H
Drug Dev Ind Pharm; 2014 May; 40(5):649-56. PubMed ID: 24506458
[TBL] [Abstract][Full Text] [Related]
11. Formulation, Optimization and Evaluation of Nanoparticulate Oral Fast Dissolving Film Dosage Form of Nitrendipine.
Gandhi NV; Deokate UA; Angadi SS
AAPS PharmSciTech; 2021 Aug; 22(6):218. PubMed ID: 34389913
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Solvent-Anti-solvent Method of Nanosuspension for Enhanced Oral Bioavailability of Lovastatin.
Patil AS; Hegde R; Gadad AP; Dandagi PM; Masareddy R; Bolmal U
Turk J Pharm Sci; 2021 Oct; 18(5):541-549. PubMed ID: 34708645
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization, optimization, and
Habib BA; Abd El-Samiae AS; El-Houssieny BM; Tag R
Drug Deliv; 2021 Dec; 28(1):1321-1333. PubMed ID: 34176376
[TBL] [Abstract][Full Text] [Related]
14.
Zayed GM; Rasoul SA; Ibrahim MA; Saddik MS; Alshora DH
Saudi Pharm J; 2020 Mar; 28(3):266-273. PubMed ID: 32194327
[TBL] [Abstract][Full Text] [Related]
15. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application.
Pawar P; Duduskar A; Waydande S
Curr Drug Res Rev; 2021; 13(1):36-48. PubMed ID: 32990554
[TBL] [Abstract][Full Text] [Related]
16. Development and Evaluation of an Anti-Epileptic Oral Fast-Dissolving Film with Enhanced Dissolution and In vivo Permeation.
Soroushnai A; Ganji F; Vasheghani-Farahani E; Mobedi H
Curr Drug Deliv; 2018; 15(9):1294-1304. PubMed ID: 30033870
[TBL] [Abstract][Full Text] [Related]
17. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Characterization of Ursodeoxycholic Acid Nanosuspension Based on Bottom-Up Technology and Box-Behnken Design Optimization.
Boscolo O; Flor S; Salvo L; Dobrecky C; Höcht C; Tripodi V; Moretton M; Lucangioli S
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631251
[TBL] [Abstract][Full Text] [Related]
19. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.
Abdelbary A; Bendas ER; Ramadan AA; Mostafa DA
AAPS PharmSciTech; 2014 Dec; 15(6):1603-10. PubMed ID: 25142820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
